BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 36811317)

  • 1. Metabolomics in oncology.
    Suri GS; Kaur G; Carbone GM; Shinde D
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1795. PubMed ID: 36811317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of metabolomics in oncology: a review.
    Spratlin JL; Serkova NJ; Eckhardt SG
    Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics in cancer research and emerging applications in clinical oncology.
    Schmidt DR; Patel R; Kirsch DG; Lewis CA; Vander Heiden MG; Locasale JW
    CA Cancer J Clin; 2021 Jul; 71(4):333-358. PubMed ID: 33982817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Metabolomics Analysis in Tumor Metabolism Reprogramming.
    Han J; Li Q; Chen Y; Yang Y
    Front Mol Biosci; 2021; 8():763902. PubMed ID: 34901157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics of cancer.
    Serkova NJ; Glunde K
    Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation.
    Bathen TF; Sitter B; Sjøbakk TE; Tessem MB; Gribbestad IS
    Cancer Res; 2010 Sep; 70(17):6692-6. PubMed ID: 20699363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The applications of metabolomics in the molecular diagnostics of cancer.
    Cheung PK; Ma MH; Tse HF; Yeung KF; Tsang HF; Chu MKM; Kan CM; Cho WCS; Ng LBW; Chan LWC; Wong SCC
    Expert Rev Mol Diagn; 2019 Sep; 19(9):785-793. PubMed ID: 31414918
    [No Abstract]   [Full Text] [Related]  

  • 8. METABOLOMICS IN MEDICAL SCIENCES--TRENDS, CHALLENGES AND PERSPECTIVES.
    Klupczyńska A; Dereziński P; Kokot ZJ
    Acta Pol Pharm; 2015; 72(4):629-41. PubMed ID: 26647618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome and Metabolomics in Liver Cancer: Scientific Technology.
    Ganesan R; Yoon SJ; Suk KT
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics: a revolution for novel cancer marker identification.
    Bu Q; Huang Y; Yan G; Cen X; Zhao YL
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics in paediatric oncology: a potential still to be exploited.
    Spiga L; Atzori L; Noto A; Moretti C; Mussap M; Masile A; Lussu M; Fanos V
    J Matern Fetal Neonatal Med; 2013 Oct; 26 Suppl 2():20-3. PubMed ID: 24059547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics: moving to the clinic.
    Nordström A; Lewensohn R
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):4-17. PubMed ID: 19399626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational metabolomics in cancer research.
    Snyder NW; Mesaros C; Blair IA
    Biomark Med; 2015; 9(9):821-34. PubMed ID: 26329905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
    Patel S; Ahmed S
    J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
    Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
    J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
    Corona G; Rizzolio F; Giordano A; Toffoli G
    J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics Applications in Precision Medicine: An Oncological Perspective.
    Puchades-Carrasco L; Pineda-Lucena A
    Curr Top Med Chem; 2017; 17(24):2740-2751. PubMed ID: 28685691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncometabolomics in cancer research.
    Gupta S; Chawla K
    Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.